SEARCH

SEARCH BY CITATION

References

  • Baron, S., Coppenhaver, D.H., Dianzani, F., Fleischmann, W.R.J., Hughes, T.K.J., Klimpel, G.R., Niesel, D.W., Stanton, G.J. and Tyring, S.K.E. (1992) Interferon: Principles and Medical Applications. Galveston, TX: University of Texas Medical Branch.
  • Belardelli, F., Ferrantini, M., Santini, S.M., Baccarini, S., Proietti, E., Colombo, M.P., Sprent, J. and Tough, D.F. (1998) The induction of in vivo proliferation of long-lived CD44hi CD8+ T cells after the injection of tumor cells expressing IFN-alpha1 into syngeneic mice. Cancer Res. 58, 57955802.
  • Birch-Machin, I., Newell, C.A., Hibberd, J.M. and Gray, J.C. (2004) Accumulation of rotavirus VP6 protein in chloroplasts of transplastomic tobacco is limited by protein stability. Plant Biotechnol. J. 2, 261270.
  • Bodo, G. and Maurer-Fogy, I. (1986) Characterization of different molecular species in affinity purified recombinant human interferon alpha 2. In: The Interferon System (Dianzani, F. and Rossi, G.B., eds), pp. 2327. New York: Raven Press.
  • Brassard, D.L., Grace, M.J. and Bordens, R.W. (2002) Interferon-alpha as an immunotherapeutic protein. J. Leukocyte Biol. 71, 565581.
  • Chebolu, S. and Daniell, H. (2007) Stable expression of GAL/GALNAc lectin of Entamoeba histolytica in transgenic chloroplast and immunogenicity in mice towards vaccine development for amebiasis. Plant Biotechnol. J. 5, 230239.
  • Collins, G.B., Legg, P.D. and Kasperbauer, M.C. (1974) Tobacco hybrid LAMD-609. Crop Sci. 14, 7280.
  • Cousens, L.P., Orange, J.S., Su, H.C. and Biron, C.A. (1997) Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection. Proc. Natl. Acad. Sci. USA, 94, 634639.
  • Cowley, G. (2002) Hepatitis C. The insidious spread of a killer virus. Newsweek, 139, 4653.
  • Cramer, C.L., Boothe, J.G. and Oishi, K.K. (1999) Transgenic plants for therapeutic proteins: linking upstream and downstream strategies. Curr. Top. Microbiol. Immunol. 240, 95118.
  • Daniell, H. (1997) Transformation and foreign gene expression in plants mediated by microprojectile bombardment. Methods Mol. Biol. 62, 463489.
  • Daniell, H. (2002) Molecular strategies for gene containment in transgenic crops. Nat. Biotechnol. 20, 581586.
  • Daniell, H., Datta, R., Varma, S., Gray, S. and Lee, S.B. (1998) Containment of herbicide resistance through genetic engineering of the chloroplast genome. Nat. Biotechnol. 16, 345348.
  • Daniell, H., Lee, S.-B., Panchal, T. and Wiebe, P.O. (2001) Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts. J. Mol. Biol. 311, 1001.
  • Daniell, H., Carmona-Sanchez, O. and Burns, B. (2004a) Chloroplast derived antibodies, biopharmaceuticals and edible vaccines. In: Molecular Farming (Fischer, R. and Schillberg, S., eds), pp. 113133. Weinheim, Germany: Wiley-VCH-Verlag.
  • Daniell, H., Kumar, S. and Dufourmantel, N. (2005a) Breakthrough in chloroplast genetic engineering of agronomically important crops. Trends Biotechnol. 23, 238245.
  • Daniell, H., Ruiz, O.N. and Dhingra, A. (2005b) Chloroplast genetic engineering to improve agronomic traits. Methods Mol. Biol. 286, 111138.
  • DeGray, G., Rajasekaran, K., Smith, F., Sanford, J. and Daniell, H. (2001) Expression of an antimicrobial peptide via the chloroplast genome to control phytopathogenic bacteria and fungi. Plant Physiol. 127, 852862.
  • De Maeyer, E. and De Maeyer-Guignard, J. (1988) Interferons and Other Regulatory Cytokines. New York: John Wiley & Sons.
  • Edelbaum, O., Stein, D., Holland, N., Gafni, Y., Livneh, O., Novick, D., Rubinstein, M. and Sela, I. (1992) Expression of active human interferon-beta in transgenic plants. J. Interferon. Res. 12, 449453.
  • Eibl, C., Zou, Z., Beck, A., Kim, M., Mullet, J. and Koop, H.U. (1999) In vivo analysis of plastid psbA, rbcL and rpl32 UTR elements by chloroplast transformation: tobacco plastid gene expression is controlled by modulation of transcript levels and translation efficiency. Plant J. 19, 333345.
  • Fernandez-San Millan, A., Mingo-Castel, A., Miller, M. and Daniell, H. (2003) A chloroplast transgenic approach to hyper-express and purify human serum albumin, a protein highly susceptible to proteolytic degradation. Plant Biotechnol. J. 1, 7179.
  • Fidler, I.J., Gersten, D.M. and Budmen, M.B. (1976) Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity. Cancer Res. 36, 31603165.
  • Gidlund, M., Orn, A., Wigzell, H., Senik, A. and Gresser, I. (1978) Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature, 273, 759761.
  • Glenz, K., Bouchon, B., Stehle, T., Wallich, R., Simon, M.M. and Warzecha, H. (2006) Production of a recombinant bacterial lipoprotein in higher plant chloroplasts. Nat. Biotechnol. 24, 7677.
  • Gresser, I., Guy-Grand, D., Maury, C. and Maunoury, M.T. (1981) Interferon induces peripheral lymphadenopathy in mice. J. Immunol. 127, 15691575.
  • Grevich, J.J. and Daniell, H. (2005) Chloroplast genetic engineering: recent advances and future perspectives. Crit. Rev. Plant Sci. 24, 83107.
  • Gutterman, J.U. (1994) Cytokine therapeutics: lessons from interferon alpha. Proc. Natl. Acad. Sci. USA, 91, 11981205.
  • Gwynne, D.I., Buxton, F.P., Pickett, M.H., Davies, R.W. and Scazzocchio, C. (1993) Vectors in Use in Filamentous Fungi. Delft, NL: Royal Gist-Brocades N.V.
  • Henco, K., Brosius, J., Fujisawa, A., Fujisawa, J.I., Haynes, J.R., Hochstadt, J., Kovacic, T., Pasek, M., Schambock, A., Schmid, J., Todokoro, K., Wälchli, M., Nagata, S. and Weissmann, C. (1985) Structural relationship of human interferon alpha genes and pseudogenes. J. Mol. Biol. 185, 227260.
  • Horn, M.E., Woodard, S.L. and Howard, J.A. (2004) Plant molecular farming: systems and products. Plant Cell Rep. 22, 711720.
  • Ishikawa, R. and Biron, C.A. (1993) IFN induction and associated changes in splenic leukocyte distribution. J. Immunol. 150, 37133727.
  • Kamarajugadda, S. and Daniell, H. (2006) Chloroplast-derived anthrax and other vaccine antigens: their immunogenic and immunoprotective properties. Expert Rev. Vaccines, 5, 839849.
  • Koya, V., Moayeri, M., Leppla, S.H. and Daniell, H. (2005) Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge. Infect. Immun. 73, 82668274.
  • Kumar, S. and Daniell, H. (2004) Engineering the chloroplast genome for hyperexpression of human therapeutic proteins and vaccine antigens. Methods Mol. Biol. 267, 365383.
  • Leelavathi, S. and Reddy, V.S. (2003) Chloroplast expression of His-tagged GUS-fusions: a general strategy to overproduce and purify foreign proteins using transplastomic plants as bioreactors. Mol. Breed. 11, 49.
  • Limaye, A., Koya, V., Samsam, M. and Daniell, H. (2006) Receptor-mediated oral delivery of a bioencapsulated green fluorescent protein expressed in transgenic chloroplasts into the mouse circulatory system. Faseb J. 20, 959961.
  • Maeda, S., Kawai, T., Obinata, M., Fujiwara, H., Horiuchi, T., Saeki, Y., Sato, Y. and Furusawa, M. (1985) Production of human alpha-interferon in silkworm using a baculovirus vector. Nature, 315, 592594.
  • Mayfield, S.P., Franklin, S.E. and Lerner, R.A. (2003) Expression and assembly of a fully active antibody in algae. Proc. Natl. Acad. Sci. USA, 100, 438442.
  • McBride, K.E., Svab, Z., Schaaf, D.J., Hogan, P.S., Stalker, D.M. and Maliga, P. (1995) Amplification of a chimeric Bacillus gene in chloroplasts leads to an extraordinary level of an insecticidal protein in tobacco. Biotechnology (NY), 13, 362365.
  • Molina, A., Hervas-Stubbs, S., Daniell, H., Mingo-Castel, A.M. and Veramendi, J. (2004) High-yield expression of a viral peptide animal vaccine in transgenic tobacco chloroplasts. Plant Biotechnol. J. 2, 141153.
  • Ohya, K., Matsumura, T., Ohashi, K., Onuma, M. and Sugimoto, C. (2001) Expression of two subtypes of human IFN-alpha in transgenic potato plants. J. Interf. Cytok. Res. 21, 595602.
  • Pestka, S., Langer, J.A., Zoon, K.C. and Samuel, C.E. (1987) Interferons and their actions. Annu. Rev. Biochem. 56, 727777.
  • Quesada-Vargas, T., Ruiz, O.N. and Daniell, H. (2005) Characterization of heterologous multigene operons in transgenic chloroplasts: transcription, processing, and translation. Plant Physiol. 138, 17461762.
  • Rubinstein, S., Familletti, P.C. and Pestka, S. (1981) Convenient assay for interferons. J. Virol. 37, 755758.
  • Ruhlman, T., Ahangari, R., Devine, A.L., Samsam, M. and Daniell, H. (2007) Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts – oral administration protects against development of insulitis in non-obese diabetic mice. Plant Biotechnol. J. (OnlineEarly Articles). doi: 10.1111/j.1467-7652.2007.00259.x
  • Ruiz, O.N. and Daniell, H. (2005) Engineering cytoplasmic male sterility via the chloroplast genome by expression of {beta}-ketothiolase. Plant Physiol. 138, 12321246.
  • Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning – A Laboratory Manual, 2nd edn. New York: Cold Spring Harbor Laboratory Press.
  • Senik, A., Gresser, I., Maury, C., Gidlund, M., Orn, A. and Wigzell, H. (1979) Enhancement by interferon of natural killer cell activity in mice. Cell Immunol. 44, 186200.
  • Slocombe, P., Easton, A., Boseley, P. and Burke, D.C. (1982) High-level expression of an interferon alpha 2 gene cloned in phage M13mp7 and subsequent purification with a monoclonal antibody. Proc. Natl. Acad. Sci. USA, 79, 54555459.
  • Staub, J.M., Garcia, B., Graves, J., Hajdukiewicz, P.T., Hunter, P., Nehra, N., Paradkar, V., Schlittler, M., Carroll, J.A., Spatola, L., Ward, D. Ye, G. and Russell, D.A. (2000) High-yield production of a human therapeutic protein in tobacco chloroplasts. Nat. Biotechnol. 18, 333338.
  • Stuart-Harris, R. and Penny, R.D. (eds) (1997) Clinical Applications of the Interferons. London: Chapman & Hall Medical.
  • Swaminathan, S. and Khanna, N. (1999) Affinity purification of recombinant interferon-alpha on a mimetic ligand adsorbent. Protein Expr. Purif. 15, 236242.
  • Tregoning, J.S., Nixon, P., Kuroda, H., Svab, Z., Clare, S., Bowe, F., Fairweather, N., Ytterberg, J., Van Wijk, K.J., Dougan, G. and Maliga, P. (2003) Expression of tetanus toxin Fragment C in tobacco chloroplasts. Nucleic Acids Res. 31, 11741179.
  • Trinchieri, G. (1989) Biology of natural killer cells. Adv. Immunol. 47, 187376.
  • Venkataraman, N., Cole, A.L., Svoboda, P., Pohl, J. and Cole, A.M. (2005) Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid. J. Immunol. 175, 75607567.
  • Vilcek, J. and Sen, G.C. (1996) Interferons and other cytokines. In: Fundamental Virology (Fields, B.N., Knipe, D.M. and Howley, P.M., eds), pp. 341365. New York: Lippincott-Raven Publishers.
  • De Waard-Siebinga, I., Creyghton, W.M., Kool, J. and Jager, M.J. (1995) Effects of interferon alfa and gamma on human uveal melanoma cells in vitro. Br. J. Ophthalmol. 79, 847855.
  • Wang, W. (1999) Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int. J. Pharm. 185, 129188.
  • Watson, J., Koya, V., Leppla, S.H. and Daniell, H. (2004) Expression of Bacillus anthracis protective antigen in transgenic chloroplasts of tobacco, a non-food/feed crop. Vaccine, 22, 43744384.
  • Wei, X., Decker, J.M., Liu, H., Zhang, Z., Arani, R.B., Kilby, J.M., Saag, M.S., Wu, X., Shaw, G.M. and Kappes, J.C. (2002) Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 46, 18961905.
  • Zhu, Z., Hughes, K.W., Huang, L., Sun, B., Liu, C. and Li, Y. (2004) Expression of human alpha-interferon cDNA in transgenic rice plants. Plant Cell Tiss. Org. 36, 197204.